JMP Securities Starts Ambrx Biopharma (AMAM) at Market Outperform; sees double in 'bull case'
Tweet Send to a Friend
(Updated - September 25, 2023 7:52 AM EDT)
JMP Securities analyst Reni Benjamin initiates coverage on Ambrx Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Reni Benjamin initiates coverage on Ambrx Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
